FDA Race/Ethnicity Data Categories Should Use Global Definitions – PhRMA
Executive Summary
FDA should use global definitions to set categories for collection of race and ethnicity data in clinical trials, the Pharmaceutical Research & Manufacturers of America said
You may also be interested in...
FDA Race/Ethnicity Data Guide Retains OMB Terms Despite Industry Criticism
FDA's final guidance for collecting and reporting race and ethnicity data in clinical trials retains Office of Management & Budget definitions despite industry concerns about applying the categories abroad
FDA Race/Ethnicity Data Guide Retains OMB Terms Despite Industry Criticism
FDA's final guidance for collecting and reporting race and ethnicity data in clinical trials retains Office of Management & Budget definitions despite industry concerns about applying the categories abroad
FDA May Revise MedWatch Reporting Methods For Race, Ethnicity Data
FDA is considering revising the way patient race and ethnicity data are collected on MedWatch adverse event reporting forms